 Wall Street brokerages forecast that Eyegate Pharmaceuticals Inc NASDAQ:EYEG will announce earnings per share EPS of 0.40 for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Eyegate Pharmaceuticals earnings. Eyegate Pharmaceuticals posted earnings of 1.15 per share during the same quarter last year, which would indicate a positive year ... 